FREE COMMUNICATION 21

08.00-09.30   G102-G103

  

Genetics
 

Chairs: Yasar Caliskan, Istanbul, Turkey
             Siren Sezer, Ankara, Turkey
 
FREE COMMUNICATIONS
 
TO001
RAB38 IS A NOVEL LOCUS FOR ALBUMINURIA IN HUMANS: THE CKDGEN CONSORTIUM
Anna Kottgen1,2, on behalf of the CKDGen Consortium 1Univ Medical Center Freiburg, Freiburg, Germany, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
 
TO002
GENOME-WIDE SCAN OF COPY NUMBER VARIATIONS (CNVS) IDENTIFIES A VARIABLE REGION
AT 3P21.1 REGULATING THE TLR9 EXPRESSION IN IGA NEPHROPATHY PATIENTS.
Fabio Sallustio1,2,3, Sharon N. Cox1, Grazia Serino1, Francesco Pesce4, Giuseppe De Palma1, Mario Falchi4, Francesco P. Schena1,2 1Univ Bari, Bari, Italy, 2Consorzio Carso, Valenzano (Bari), Italy, 3Univ Salento, Lece, Italy, 4Imperial
College London, London, UK
 
TO003
A COMBINED MIRNA BIOMARKER FOR NON-INVASIVE DIAGNOSIS OF IDIOPATHIC IGA
NEPHROPATHY: AN INTERNATIONAL MULTICENTRE STUDY (NIDIGAN STUDY)
Francesco P Schena1,2, Grazia Serino1,2, Fabio Sallustio1,2, Francesco Pesce1,3, Giuseppe De Palma2, Sharon N Cox1, Kar N Lai4, Joseph CK Leung4, Aikaterini Papagianni5, Maria Stangou5, Dimitrios Goumenos6, Miltiadis Gerolymos6, Kazuo Takahashi7, Yukio Yuzawa7, Shoichi Maruyama8, Enyu Imai8 1Univ Bari, Bari, Italy, 2C.A.R.S.O. Consortium, Valenzano (BA), Italy, 3Imperial College London, London, UK, 4Univ Hong-Kong, Hong-Kong, Hong Kong, 5Aristotle Univ Thessaloniki, Hippokration General Hosp, Thessaloniki, Greece, 6Univ Hosp Patras, Patras, Greece, 7Fujita Health Univ School of Medicine, Toyake, Japan, 8Nagoya Univ Graduate School of Medicine, Nagoya, Japan
 
TO004
ACUTE INTERMITTENT PORPHYRIA : AN UNDERDIAGNOSED CAUSE OF CHRONIC KIDNEY DISEASE
Alexandre Karras1, Iadh Mami2, Caroline Schmitt3, Dominique Nochy1, Marion Rabant4, Alexandre
Hertig5, Marc Vincent2, Eric Thervet1, Hervé Puy3, Nicolas Pallet1 1HEGP Hosp, Paris, France, 2Centre Univ Des Saints Pères, Paris, France,3Hop Louis Mourrier, Colombes, France, 4Necker Hosp, Paris, France, 5Tenon Hosp, Paris, France
 
TO005
PRESENTATION OF RENAL ANGIOMYOLIPOMA AND MORTALITY IN TUBEROUS SCLEROSIS IN
THE NETHERLANDS
Bernard Zonnenberg1, Marinus J.C. Eijkemans2, Leida Reijnders1, Sahar Khosrovani3, Matthew Magestro4 1Univ Medical Center Utrecht, Utrecht, Netherlands, 2Julius Center Health Sciences and Primary Care, Univ Medical Center Utrecht, Utrecht, Netherlands, 3Novartis Netherlands, Arnhem, Netherlands, 4Novartis Pharmaceuticals Corporation, East Hanover, NJ
 
TO006
EFFECT OF EVEROLIMUS ON RENAL FUNCTION IN PATIENTS WITH TUBEROUS SCLEROSIS
COMPLEX (TSC): RESULTS FROM EXIST-1 AND EXIST-2
John J Bissler1, J Christopher Kingswood2, Bernard A Zonnenberg3, Michael Frost4, Elena Belousova5,
Matthias Sauter6, Noah Berkowitz7, Sara Miao7, Scott Segal7, Thomas Brechenmacher8, Klemens Budde9, David Neal Franz10 1Le Bonheur Children’s Hosp, Memphis, TN; 2Royal Sussex County Hosp, Brighton, UK, 3Univ Medisch Centrum, Utrecht, Netherlands, 4Minnesota Epilepsy Group, St Paul, MN; 5Moscow Research Inst Pediatrics & Pediatric Surgery, Moscow, Russian Federation, 6Medizinische Klinik Und Poliklinik IV, Klinikum Univ München, Munich, Germany, 7Novartis Pharmaceuticals Corporation, East Hanover, NJ; 8Novartis Pharmaceuticals S.A.S., Rueil-Malmaison, France, 9Charité Univrsitätsmedizin, Berlin, Germany, 10Cincinnati Children’s Hosp Medical Center, Cincinnati, OH
    

back to the timetable